CONMED Retained Earnings (Accumulated Deficit) 2010-2024 | CNMD

CONMED retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
CONMED Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $453
2022 $413
2021 $497
2020 $457
2019 $471
2018 $465
2017 $440
2016 $407
2015 $415
2014 $406
2013 $396
2012 $378
2011 $354
2010 $354
2009 $325
CONMED Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $533
2024-06-30 $490
2024-03-31 $466
2023-12-31 $453
2023-09-30 $426
2023-06-30 $416
2023-03-31 $408
2022-12-31 $413
2022-09-30 $392
2022-06-30 $352
2022-03-31 $526
2021-12-31 $497
2021-09-30 $478
2021-06-30 $469
2021-03-31 $461
2020-12-31 $457
2020-09-30 $439
2020-06-30 $438
2020-03-31 $471
2019-12-31 $471
2019-09-30 $462
2019-06-30 $460
2019-03-31 $460
2018-12-31 $465
2018-09-30 $449
2018-06-30 $449
2018-03-31 $446
2017-12-31 $440
2017-09-30 $399
2017-06-30 $397
2017-03-31 $397
2016-12-31 $407
2016-09-30 $406
2016-06-30 $404
2016-03-31 $407
2015-12-31 $415
2015-09-30 $412
2015-06-30 $409
2015-03-31 $407
2014-12-31 $406
2014-09-30 $400
2014-06-30 $404
2014-03-31 $399
2013-12-31 $396
2013-09-30 $391
2013-06-30 $390
2013-03-31 $384
2012-12-31 $378
2012-09-30 $371
2012-06-30 $366
2012-03-31 $360
2011-12-31 $354
2011-09-30 $380
2011-06-30 $371
2011-03-31 $363
2010-12-31 $354
2010-09-30 $348
2010-06-30 $339
2010-03-31 $333
2009-12-31 $325
2009-09-30 $321
2009-06-30 $320
2009-03-31 $319
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.215B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49